P

Inventor

DESAI DIPEN

US50 patents
⚠️ This page may combine multiple inventors who share the name “DESAI DIPEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KASHIV BIOSCIENCES LLC

14 patents
US10869839B2Dec 22, 2020

Extended release compositions comprising trihexyphenidyl

KASHIV BIOSCIENCES LLC5 citations84
US10898431B2Jan 26, 2021

Programmable pharmaceutical compositions for chrono drug release

KASHIV BIOSCIENCES LLC8 citations83
US10898430B2Jan 26, 2021

Self-regulating osmotic gastroretentive drug delivery systems

KASHIV BIOSCIENCES LLC5 citations83
US10849846B2Dec 1, 2020

Self-regulating osmotic gastroretentive drug delivery systems

KASHIV BIOSCIENCES LLC6 citations83
US10744083B2Aug 18, 2020

Self-regulating osmotic gastroretentive drug delivery systems

KASHIV BIOSCIENCES LLC6 citations83
US11229606B2Jan 25, 2022

Extended release compositions comprising pyridostigmine

KASHIV BIOSCIENCES LLC1 citations73
US10987311B2Apr 27, 2021

Extended release compositions comprising pyridostigmine

KASHIV BIOSCIENCES LLC2 citations73
US10744093B2Aug 18, 2020

Extended release compositions comprising pyridostigmine

KASHIV BIOSCIENCES LLC2 citations73
US10588863B2Mar 17, 2020

Extended release compositions comprising pyridostigmine

KASHIV BIOSCIENCES LLC2 citations73
US10406234B2Sep 10, 2019

Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage forms

KASHIV BIOSCIENCES LLC2 citations73
US10857098B2Dec 8, 2020

Gastroretentive dosage forms for sustained drug delivery

KASHIV BIOSCIENCES LLC1 citations71
US10500282B2Dec 10, 2019

Supersaturated stabilized nanoparticles for poorly soluble drugs

KASHIV BIOSCIENCES LLC2 citations71
US10744131B2Aug 18, 2020

Abuse-resistant drug formulations

KASHIV BIOSCIENCES LLC0 citations40
US10632113B2Apr 28, 2020

Abuse-resistant drug formulations with built-in overdose protection

KASHIV BIOSCIENCES LLC0 citations40

KASHIV SPECIALTY PHARMACEUTICALS LLC

13 patents
US11179320B2Nov 23, 2021

Self-regulating osmotic gastroretentive drug delivery systems

KASHIV SPECIALTY PHARMACEUTICALS LLC3 citations83
US11000471B2May 11, 2021

Programmable pharmaceutical compositions for chrono drug release

KASHIV SPECIALTY PHARMACEUTICALS LLC3 citations83
US10980738B2Apr 20, 2021

Programmable pharmaceutical compositions for chrono drug release

KASHIV SPECIALTY PHARMACEUTICALS LLC5 citations83
US11478425B2Oct 25, 2022

Extended release compositions comprising pyridostigmine

KASHIV SPECIALTY PHARMACEUTICALS LLC2 citations73
US11154505B1Oct 26, 2021

Extended release compositions comprising trihexyphenidyl

KASHIV SPECIALTY PHARMACEUTICALS LLC3 citations73
US11045420B2Jun 29, 2021

Extended release compositions comprising trihexyphenidyl

KASHIV SPECIALTY PHARMACEUTICALS LLC4 citations73
US11040014B2Jun 22, 2021

Extended release compositions comprising trihexyphenidyl

KASHIV SPECIALTY PHARMACEUTICALS LLC4 citations73
US10925833B2Feb 23, 2021

Extended release compositions comprising pyridostigmine

KASHIV SPECIALTY PHARMACEUTICALS LLC2 citations73
US10881617B1Jan 5, 2021

Extended release compositions comprising pyridostigmine

KASHIV SPECIALTY PHARMACEUTICALS LLC2 citations73
US11154494B2Oct 26, 2021

Programmable pharmaceutical compositions for chrono drug release

KASHIV SPECIALTY PHARMACEUTICALS LLC1 citations72
US10952957B2Mar 23, 2021

Self-regulating osmotic gastroretentive drug delivery systems

KASHIV SPECIALTY PHARMACEUTICALS LLC2 citations72
US11007145B2May 18, 2021

Gastroretentive dosage forms for sustained drug delivery

KASHIV SPECIALTY PHARMACEUTICALS LLC1 citations71
US11564888B2Jan 31, 2023

Extended release compositions comprising trihexyphenidyl

KASHIV SPECIALTY PHARMACEUTICALS LLC0 citations62

AMNEAL COMPLEX PRODUCTS RES LLC

13 patents
US11166906B2Nov 9, 2021

Programmable pharmaceutical compositions for chrono drug release

AMNEAL COMPLEX PRODUCTS RES LLC3 citations83
US11793747B2Oct 24, 2023

Self-regulating osmotic gastroretentive drug delivery systems

AMNEAL COMPLEX PRODUCTS RES LLC1 citations72
US11684580B2Jun 27, 2023

Extended release compositions comprising trihexyphenidyl

AMNEAL COMPLEX PRODUCTS RES LLC1 citations72
US11666536B2Jun 6, 2023

Extended release compositions comprising pyridostigmine

AMNEAL COMPLEX PRODUCTS RES LLC1 citations72
US11464742B2Oct 11, 2022

Extended release compositions comprising trihexyphenidyl

AMNEAL COMPLEX PRODUCTS RES LLC1 citations72
US11419813B2Aug 23, 2022

Programmable pharmaceutical compositions for chrono drug release

AMNEAL COMPLEX PRODUCTS RES LLC1 citations72
US11318091B2May 3, 2022

Gastroretentive dosage forms for sustained drug delivery

AMNEAL COMPLEX PRODUCTS RES LLC1 citations71
US12233166B2Feb 25, 2025

Extended release compositions comprising pyridostigmine

AMNEAL COMPLEX PRODUCTS RES LLC0 citations62
US11964048B2Apr 23, 2024

Sustained release compositions comprising liothyronine

AMNEAL COMPLEX PRODUCTS RES LLC1 citations62
US11911515B2Feb 27, 2024

Extended release compositions comprising pyridostigmine

AMNEAL COMPLEX PRODUCTS RES LLC0 citations62
US11439585B2Sep 13, 2022

Programmable pharmaceutical compositions for chrono drug release

AMNEAL COMPLEX PRODUCTS RES LLC0 citations61
US12042559B2Jul 23, 2024

Gastroretentive dosage forms for sustained drug delivery

AMNEAL COMPLEX PRODUCTS RES LLC0 citations59
US11547670B2Jan 10, 2023

Delayed release methylphenidate compositions

AMNEAL COMPLEX PRODUCTS RES LLC0 citations51

KASHIV PHARMA LLC

7 patents

DESAI DIPEN

1 patent

PLEXXIKON INC

1 patent

CHATTERJI ASHISH

1 patent